Sertraline HCL Tablets
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D220R0067
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents5
The Defense Logistics Agency (DLA) Troop Support has issued an award notice for the procurement of Sertraline HCL Tablets, as detailed under procurement identifier SPE2D220R0067. This procurement is classified under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further identified by Product Service Code 6505, indicating a focus on pharmaceutical products.
The scope of this procurement encompasses the supply of Sertraline HCL Tablets in multiple dosage strengths and packaging configurations. Specifically, the requirement includes Sertraline HCL Tablets in 25MG and 50MG strengths, to be delivered in bottles containing 30, 90, 180, and 500 tablets. Additionally, there is a requirement for Sertraline HCL Tablets in an unspecified strength to be provided in bottles of 30, 60, 90, 180, and 500 count. The intent of this procurement is to ensure a reliable supply of these pharmaceutical products to meet the ongoing needs of the agency and its supported entities.
The place of performance for this contract is Hauppauge, New York, United States. Contractors should note that the DLA Troop Support, a federal office, is the contracting entity responsible for this procurement. The primary point of contact for this opportunity is Keith Ryales, who can be reached via email at [email protected] for any inquiries related to the contract.
This award notice is currently active, as of the posting date of June 13, 2025. The opportunity was sourced through BIDMATCH_SAM and is available for review on the SAM.gov portal, with the opportunity ID 69b006e769cd4851aae7794401697064. Interested parties can access up to five attachments related to this notice for further details.
Contractors considering this opportunity should be capable of manufacturing and supplying pharmaceutical preparations in compliance with federal standards, and must be able to deliver the specified Sertraline HCL Tablet products in the required quantities and packaging formats. While the notice does not specify set-aside requirements or special considerations, it is essential for interested vendors to review all provided documentation and attachments to ensure full compliance with the contract terms and conditions.
This procurement represents a significant opportunity for qualified pharmaceutical manufacturers to support the DLA Troop Support’s mission by providing essential medication in a timely and reliable manner.